Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders - Wikidata - wikimedia - TriplyDB

Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders

Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders

http://www.wikidata.org/entity/Q35649045

about

Misclassification in administrative claims data: quantifying the impact on treatment effect estimates.Does the association between adherence to statin medications and mortality depend on measurement approach? A retrospective cohort study Prescription medication burden in patients with newly diagnosed diabetes: a SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) study.Impact of the New ACC/AHA Guidelines on the Treatment of High Blood Cholesterol in a Managed Care Setting.Examining Dose of Diabetes Group Medical Visits and Characteristics of the Uninsured Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system.Ethnic disparities in adherence to antihypertensive medications of medicare part D beneficiaries.Improving Patient's Primary Medication Adherence: The Value of Pharmaceutical Counseling Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques.Randomized trial of telephone outreach to improve medication adherence and metabolic control in adults with diabetes.Non-adherence in type 2 diabetes: practical considerations for interpreting the literature Primary adherence to antidepressant prescriptions in primary health care: a population-based study in Sweden.Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases Potentially disruptive life events: what are the immediate impacts on chronic disease management? A case-crossover analysis.Improving adherence with medication: a selective literature review based on the example of hypertension treatment.Depressive symptoms and adherence to cardiometabolic therapies across phases of treatment among adults with diabetes: the Diabetes Study of Northern California (DISTANCE)When compliance is an issue-how to enhance statin adherence and address adverse effects.Impact of initial medication non-adherence on use of healthcare services and sick leave: a longitudinal study in a large primary care cohort in Spain.Use of pharmacy records to measure treatment adherence: a critical review of the literature.Influence of route of administration/drug formulation and other factors on adherence to treatment in rheumatoid arthritis (pain related) and dyslipidemia (non-pain related).Comprehensive efforts to increase adherence to statin therapy.Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors.Do patients initiate therapy? Primary non-adherence to statins and antidepressants in Iceland.Factors predicting self-reported medication low adherence in a large sample of adults in the US general population: a cross-sectional study.Primary non-adherence to bisphosphonates in an integrated healthcare setting.Initial antihyperglycemic drug therapy among 241 327 adults with newly identified diabetes from 2005 through 2010: a surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) study.An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health System.Relationships between Medication Adherence and Cardiovascular Disease Risk Factor Control in Elderly Patients with Diabetes.Primary non-adherence and the new-user design.Primary nonadherence to chronic disease medications: a meta-analysis.

P2860

Q30974376-96065D99-26E6-4E15-BA8A-C97CD10E4584 Q33582496-36C87F9E-41C9-4EF2-AB27-9279842C722C Q34167629-5FF0DE61-C09C-4B1D-9C3D-55ADCC927F33 Q34792459-2005183B-BD5E-45D5-8059-74A05A56F721 Q35050171-D060B866-0CDF-477F-8C2C-8A7B84055110 Q35177409-C06FB312-B2E7-4651-A1A0-AF8D30EE0E45 Q36094813-1449375B-D77F-4897-8DC4-CCE32D04B4E0 Q36195544-8972265A-362B-4D95-9F81-E6E5C56ED3F9 Q36484334-E30E4EA0-105D-4E70-828C-22486A170E3E Q36488716-F483D23C-19CE-4C2E-82AF-1A7A473AEC51 Q36574264-E67EFF70-69DD-46A6-A786-467B337F4FFA Q36669031-AA44A10C-8908-4FD3-9520-1574BCDB8987 Q37013552-7F446B3D-F35E-4114-942C-4C4A7F1EBEC2 Q37055744-097E3886-6101-433B-B286-2AA259B15F29 Q37177541-84BA127C-A14D-4AF9-9B07-727A23E01247 Q37632055-6ED25575-AAA1-40D3-B698-ECD86B3208A8 Q37730586-871A1B33-D144-424C-B837-6EEFEBFB7F01 Q38269606-29EE4331-7828-436D-93C8-D1B50C04F6C3 Q38650936-FDE4C0A5-4863-40C2-B31A-1FB89C5260B1 Q38819475-F59E633E-BB6B-48F5-A5B7-5DE7D730A835 Q38867559-6F34DEFA-7AB5-41BE-BDFB-13EA776930CE Q39080414-CA883CB6-DBDC-4A2A-BE26-2CF1AD21784C Q40483088-F00E3964-1214-4819-B983-3A05B81D1680 Q41484191-10DB1CC6-DCD7-4156-A157-0F62A5F6E0FE Q42145841-44AE449C-F5C1-4242-B465-7C0E29B44839 Q44164234-A07B6682-4163-4C31-B481-54FE9B365F3C Q44449274-1A1CC2D0-20A5-4D91-B370-3D10FFA1C145 Q45175635-5620E4C0-253B-449C-9465-27DC0D7F3C02 Q45933478-1085E550-00FB-44EC-91AC-0C7867761F86 Q49822791-E4E5D169-4B56-4F97-B52C-F4A2B4D9D78D Q55262809-3C3B97ED-4D76-4294-8944-B7DE944880A4

P2860

Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders

http://www.wikidata.org/entity/Q35649045

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Characteristics of patients wi ...... diabetes, and lipid disorders

@ast

Characteristics of patients wi ...... diabetes, and lipid disorders

@en

type

label

Characteristics of patients wi ...... diabetes, and lipid disorders

@ast

Characteristics of patients wi ...... diabetes, and lipid disorders

@en

prefLabel

Characteristics of patients wi ...... diabetes, and lipid disorders

@ast

Characteristics of patients wi ...... diabetes, and lipid disorders

@en

P1433

Q35649045-90BD30F0-397B-4524-96A1-6F974D09CECA

P1476

Q35649045-F521F644-82D6-4A1D-84BA-7AF3C61A9CD1

P2093

Q35649045-21903ABF-729B-499E-9CC5-3E560EED4BA4

Q35649045-34FEB5E0-505B-4CDF-8CF7-2D79CD28D28B

Q35649045-4FBAB151-99D5-4B54-BA62-652187C591D0

Q35649045-7892047D-69F3-447E-8B9F-ACB0BBA32D26

Q35649045-900CAD5D-9F6F-4EF9-BC7E-0DAC25C0AD3B

Q35649045-9FB15BB1-F3CB-445C-950A-930D6ED60ED2

Q35649045-AD052D09-145E-46C9-AB37-B92B8ED60587

Q35649045-AD16551F-BBBE-4AFC-A264-06A13C2F02D6

Q35649045-BD255590-635C-495E-8E52-0FCE142DC4E5

P2860

Q35649045-018B587B-9140-4F28-9BBA-E5AFB9A456B6

Q35649045-19CEDE85-9401-40FB-9ABE-48DBEFA272E2

Q35649045-1E00493A-BCE9-4008-B929-B8C762783475

Q35649045-210FC5D9-7AB4-4634-8290-5D7DC2B7C7D5

Q35649045-2FB14A5C-63FC-4BD7-B108-D6CFD58058C8

Q35649045-382E0327-7827-427F-837A-3B7C3E08DF5F

Q35649045-625B4E03-5DA2-49B7-B1D8-E21BE28BF189

Q35649045-626306C5-B4F8-4B3F-A62B-51566B58C65C

Q35649045-66861E95-2D2A-4A1C-B239-2E3DA941B3E1

Q35649045-7C4E1CE6-3E00-4258-9FC9-67CCBDE7835A

P2888

Q35649045-A52B3402-9AC2-41BE-943E-DF68D0E8136C

P304

Q35649045-8E65DC58-4630-491B-9F19-E200CFA6412A

P31

Q35649045-C7D492D4-C227-42D2-98EC-EB1BF17C7E0C

P356

Q35649045-F2162DB5-55E2-4D5F-B60B-4BD180E62978

P433

Q35649045-5034EFDF-AD18-4DCC-9FE7-905A8F43615C

P478

Q35649045-434FF290-F020-45BA-9D3F-88639FAAA4B3

P577

Q35649045-8CD79AE3-FD25-47B3-A739-FF55E88E02FD

P5875

Q35649045-BA11BA71-FB96-4B37-AD38-0BCA8E256067

P698

Q35649045-86830222-F44F-4378-87AF-2B517C594B22

P932

Q35649045-3A59CAFD-63E9-4F4C-84EB-409C39F5A8F2

P356

S11606-011-1829-Z

P1433

Journal of General Internal Medicine

P1476

Characteristics of patients wi ...... diabetes, and lipid disorders

@en

P2093

Brandy McGinnis

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Bayliss

http://www.w3.org/2001/XMLSchema#string

Emily B Schroeder

http://www.w3.org/2001/XMLSchema#string

Jennifer L Ellis

http://www.w3.org/2001/XMLSchema#string

John F Steiner

http://www.w3.org/2001/XMLSchema#string

Marsha A Raebel

http://www.w3.org/2001/XMLSchema#string

Nikki M Carroll

http://www.w3.org/2001/XMLSchema#string

Stan Xu

http://www.w3.org/2001/XMLSchema#string

Susan Shetterly

http://www.w3.org/2001/XMLSchema#string

P2860

Primary medication non-adherence: analysis of 195,930 electronic prescriptions

Factors associated with first-fill adherence rates for diabetic medications: a cohort study

Predictors of first-fill adherence for patients with hypertension

Adherence to Medication

Physician communication and patient adherence to treatment: a meta-analysis.

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

Impact of prescription size on statin adherence and cholesterol levels

Patients' perspectives on nonadherence to statin therapy: a focus-group study.

Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter?

Primary non-compliance with prescribed medication in primary care

P2888

s11606-011-1829-z

P304

57-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11606-011-1829-Z

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51607139

http://www.w3.org/2001/XMLSchema#string

P698

21879374

http://www.w3.org/2001/XMLSchema#string

P932

3250550

http://www.w3.org/2001/XMLSchema#string